Skip to main content
Premium Trial:

Request an Annual Quote

Icoria Wins $800K SBIR Contract to Study Gene Expression of Alcohol-Related Diseases

NEW YORK, Oct. 20 (GenomeWeb News) - Icoria has received a Small Business Innovation Research contract worth around $800,000 from the National Institute on Alcohol Abuse and Alcoholism $800,000.


The Phase II contract will help pay for Icoria's metabolomics and gene expression-analysis research of alcohol-related diseases, including liver and brain injury, according to the company. The study is called "Metabolomics: Alcohol Induced Toxicity."

The contract is the second Phase II SBIR contract Icoria has received. The company received a $1.2 million contract this summer. "Together, the two Phase II SBIR contracts help to support our biomarker discovery efforts on a broad set of liver pathologies that span a variety of mechanisms," Thomas Colatsky, Icoria's CSO, said in a statement today.


"By using metabolomics and gene expression to analyze different forms of liver toxicity, we hope to identify new biomarkers for liver disease that should have utility in the development of highly-informative, minimally invasive diagnostics covering acute as well as more chronic liver-related diseases, including alcoholic and non-alcoholic fatty liver disease."

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.